To block protein-antibody complex formation during immunochemical analysis of COX-2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

COX-2 (human) Blocking Peptide

Item No. 360107

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Cyclooxygenase 2
  • PGHS-2
  • Prostaglandin H Synthase 2
Amino Acids
Human COX-2 amino acids 567-599 (SVPDPELIKTVTINASSSRSGLDDINPTVLLKE)
Formulation (Request formulation change)
A lyophilized peptide
Solubility(Learn about Variance in Solubility)
water: 10 mg/ml
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    200 µg

    $146

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    To be used in conjunction with Cayman’s COX-2 (human) Polyclonal Antibody (Item No. 160107) or the COX-2 (human) monoclonal antibodies (Item Nos. 160112 | 160113) to block protein-antibody complex formation during immunochemical analysis for COX-2.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Citations

    Urban, J., and Kuźbicki, Ł. Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients. BMC Cancer 14, 732 (2014).

    Bhandari, P., Bateman, A.C., Mehta, R.L., et al. Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer 6, 134 (2006).

    Boland, G.P., Butt, I.S., Prasad, R., et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br. J. Cancer 90(2), 423-429 (2004).

    Ristimäki, A., Nieminen, O., Saukkonen, K., et al. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am. J. Pathol. 158, 849-853 (2001).